Lincoln Alternative shows 0% ownership stake in GRO Bio (GRI)

Rhea-AI Filing Summary

GRO Bio, Inc. received an amended Schedule 13G from Lincoln Alternative Strategies LLC reporting that it now beneficially owns 0 shares of GRO Bio common stock, representing 0% of the class. The filer confirms it owns 5 percent or less of the company’s common stock.

Lincoln Alternative reports no sole or shared voting or dispositive power over any GRO Bio shares and certifies the securities are not held to change or influence control of the issuer. The filing formally updates regulatory records to reflect the firm’s lack of beneficial ownership.

Insights

Equity ownership and disclosure analyst

Lincoln Alternative updates its GRO Bio stake to 0% beneficial ownership.

Lincoln Alternative Strategies LLC reports beneficial ownership of 0 GRO Bio common shares, or 0% of the class. It also reports zero sole or shared voting and dispositive power, indicating no current economic or governance stake under Schedule 13G definitions.

The filer notes it owns 5 percent or less of the class and certifies the position is not held to change or influence control. This amendment mainly refreshes ownership records; actual market impact depends on when and how the underlying position changed, which is not detailed in the disclosure.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

GRO Bio, Inc.

(Name of Issuer)

Common stock, par value $0.0001 per share

(Title of Class of Securities)

3622AW403

(CUSIP Number)

12/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 3622AW403

1

Names of Reporting Persons

Lincoln Alternative Strategies LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GRO Bio, Inc.
(b)	Address of issuer's principal executive offices: 2223 Avenida de la Playa, #208, La Jolla, CA, 92037
Item 2.
(a)	Name of person filing: Lincoln Alternative Strategies LLC
(b)	Address or principal business office or, if none, residence: 404 Washington Ave., Suite 650, Miami Beach, FL 33139
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common stock, par value $0.0001 per share
(e)	CUSIP No.: 3622AW403
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lincoln Alternative Strategies LLC

Signature:	/s/ Stephen Temes
Name/Title:	Stephen Temes/Managing Member
Date:	02/10/2026

FAQ

What does Lincoln Alternative Strategies report in this GRO Bio (GRI) Schedule 13G/A?

Lincoln Alternative Strategies LLC reports beneficial ownership of 0 shares of GRO Bio common stock, representing 0% of the class. The firm also reports no sole or shared voting or dispositive power over any GRO Bio shares in this amended filing.

Is Lincoln Alternative Strategies still a 5% shareholder of GRO Bio (GRI)?

No. Lincoln Alternative Strategies LLC states it owns 5 percent or less of GRO Bio’s common stock, with an aggregate beneficial ownership of 0 shares. As a result, its reported ownership percentage is 0% of the outstanding common stock class.

What class of GRO Bio (GRI) securities is covered in this Schedule 13G/A?

The filing covers GRO Bio, Inc. common stock with a par value of $0.0001 per share, identified by CUSIP 3622AW403. All ownership figures and percentages in the report relate specifically to this class of common stock only.

What ownership powers does Lincoln Alternative report over GRO Bio (GRI) shares?

Lincoln Alternative Strategies LLC reports zero sole or shared power to vote or direct the vote, and zero sole or shared power to dispose or direct the disposition of any GRO Bio common shares, confirming the absence of beneficial ownership authority.

What certification does Lincoln Alternative give about its intent regarding GRO Bio (GRI)?

Lincoln Alternative certifies that the referenced securities were not acquired and are not held for the purpose or effect of changing or influencing control of GRO Bio. It also states they are not held as part of any transaction with that purpose or effect.

Who signed the amended GRO Bio (GRI) Schedule 13G/A for Lincoln Alternative?

The amended Schedule 13G/A was signed by Stephen Temes, identified as Managing Member of Lincoln Alternative Strategies LLC. The signature block certifies that, to the best of his knowledge and belief, the information reported is true, complete, and correct.